# Blood-based Biomarkers for Diagnosis of Alzheimer's

> **NCT05187819** · NA · RECRUITING · sponsor: **Helse Stavanger HF** · enrollment: 300 (estimated)

## Conditions studied

- Dementia Alzheimers

## Interventions

- **DIAGNOSTIC_TEST:** predictive value of a blood test

## Key facts

- **NCT ID:** NCT05187819
- **Lead sponsor:** Helse Stavanger HF
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05187819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05187819, "Blood-based Biomarkers for Diagnosis of Alzheimer's". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05187819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*